Subscribe to RSS
DOI: 10.1055/s-0030-1258036
Synthesis of New 2-Benzazepino[4,5-a]naphthalene Derivatives via 1,7-Electrocyclisation of Nonstabilised Azomethine Ylides
Publication History
Publication Date:
12 August 2010 (online)
Abstract
Novel 2-benzazepino[4,5-a]naphthalene derivatives were synthesised efficiently via 1,7-electrocyclisation of nonstabilised azomethine ylides derived from 1-aryl- or 1-alkenyl-naphthalene-2-carbaldehyde derivatives. In some cases, surprisingly, pyrrole derivatives were isolated. A mechanism for the formation of the pyrrole byproduct is proposed.
Key words
Azepines - electrocyclic reactions - heterocycles - tandem reactions - ylides
- 1
Seven-membered Heterocyclic
Rings and their Fused Derivatives, In Comprehensive Heterocyclic
Chemistry III
Vol. 13:
Newkome GR. Elsevier Science; Oxford: 2008. - 2
Kouznetsov V.Palma A.Ewert C. Curr. Org. Chem. 2001, 5: 519 - 3
Synthetic Applications of
1,3-Dipolar Cycloaddition Chemistry Toward Heterocycles and Natural
Products
Padwa A.Pearson WH. Wiley; New York: 2002. - 4
Tsuge O.Kanemasa S. Adv. Heterocycl. Chem. 1989, 45: 232 - 5
Taylor EC.Turchi IJ. Chem. Rev. 1979, 79: 181 - 6
Huisgen R. Angew. Chem., Int. Ed. Engl. 1980, 19: 947 - 7
Zecchi G. Synthesis 1991, 181 - 8
Groundwater PW.Nyerges M. Advances in Heterocyclic Chemistry Vol. 73:Katritzky AR. Academic Press; New York: 1999. p.97 - 9
Pinho e Melo TMVD. Eur. J. Org. Chem. 2006, 2873 - 10
Tan Y.Hartmann T.Huch V.Dürr H.Valat P.Wintgens V.Kossanyi J. J. Org. Chem. 2001, 66: 1130 - 11
Friebolin W.Eberbach W. Tetrahedron 2001, 57: 4349 - 12
Reinhard R.Glaser M.Neumann R.Maas G. J. Org. Chem. 1997, 62: 7744 - 13
Marx K.Eberbach W. Tetrahedron 1997, 53: 14687 - 14
Knobloch K.Eberbach W. Eur. J. Org. Chem. 2002, 2054 - 15
Ma Y.Weber C.Hartmann T.Dürr H.Krüger C.Kossanyi J. Synthesis 2001, 1812 - 16
Arany A.Bendell D.Groundwater PW.Garnett I.Nyerges M. J. Chem. Soc., Perkin Trans. 1 1999, 2605 - 17
Nyerges M.Pintér .Virányi A.Bitter I.Tőke L. Tetrahedron Lett. 2005, 46: 377 - 18
Nyerges M.Virányi A.Tóth J.Blaskó G.Tőke L. Synthesis 2006, 1273 - 19
Tóth J.Dancsó A.Blaskó G.Tőke L.Groundwater PW.Nyerges M. Tetrahedron 2006, 62: 5725 - 20
Nyerges M.Tóth J.Groundwater PW. Synlett 2008, 1269 - 21
Moleele SS.Michael JP.De Koning CB. Tetrahedron 2006, 62: 2831 - 23
Samanta S.Jana R.Ray JK. Tetrahedron Lett. 2009, 50: 6751 - 24 Computed at B3LYP/6-31G(d,p)
level of theory by using Gaussian 03 program.
Frisch MJ. Gaussian 03 6.0 Gaussian Inc.; Pittsburg: 2003. - 25
Mucsi Z.Chass GA.Viskolcz B.Csizmadia IG.
J. Phys. Chem. A 2009, 113: 7953 - 26
Stevens TS.Creighton EM.Gordon AB.MacNicol M. J. Chem. Soc. 1928, 3193 - 27
Johnstone RAW.Stevens TS. J. Chem. Soc. 1955, 4487 - 28
Ollis WD.Rey M.Sutherland IO. J. Chem. Soc., Perkin Trans. 1 1983, 1009 - 29
Vanecko JA.Wan H.West FG. Tetrahedron 2006, 62: 1043
References and Notes
Experimental Procedure
for 1,7-Electrocyclisation Reactions
The aldehyde
(3 or 19, 1.0
mmol) was dissolved in xylene (50 mL), and the corresponding amino
acid (2.0 mmol) was added. The reaction mixture was refluxed under
Dean-Stark conditions and further portions of the amino
acid (1.0 mmol) were added every 2 h until the starting aldehyde
completely disappeared (2-6 h) judged by TLC. All the solvent
was removed in vacuo, and the residue was purified by column chromatography
(eluent: heptane-EtOAc).
Selected
Data of Representative Examples
Compound 6a: ¹H NMR (400 MHz,
CDCl3): δ = 7.24 (d, 1 H, J = 8.0
Hz, H-13), 6.97 (d, 1 H, J = 8.4 Hz, H-1), 6.92 (d, 1 H,
J = 2.0 Hz, H-10), 6.90 (dd, 1 H, J = 8.0, 2.0
Hz, H-12), 6.78 (d, 1 H, J = 2.8 Hz, H-4), 6.65 (d, 1 H,
J = 8.4, 2.8 Hz, H-2), 3.86 (s, 3 H, OMe), 3.81 (s, 3 H,
OMe), 3.45 (br m, 1 H, H-5), 3.40 (br m, 1 H, H-5), 3.03 (br m,
1 H, H-7), 2.97 (br m, 2 H, H-7 and H-9), 2.76 (br m, 2 H, H-8 and
H-9), 2.42 (br m, 1 H, H-8), 2.41 (s, 3 H, NMe). ¹³C
NMR (100 MHz, CDCl3): δ = 158.3 (q),
138.5 (2 × q), 137.9 (q), 134.9 (q), 131.5
(q), 130.6 (q), 129.6 (CH), 127.7 (q), 127.1 (CH), 114.7 (CH), 113.8
(CH), 112.9 (CH), 110.8 (CH), 58.1 (CH2), 57.8 (CH2),
55.4 (2 × CH3), 43.8 (CH3),
31.3 (CH2), 29.1 (CH2). IR (KBr): 2935, 1605,
1251 cm-¹.
Compound 13b: ¹H NMR (500 MHz,
DMSO-d6): δ = 8.06 (s, 1 H, H-12),
7.96 (d, 1 H, J = 8.0 Hz, H-14), 7.36 (d, 1 H, J = 8.0
Hz, H-15), 6.84 (d, 1 H, J = 1.9 Hz, H-4), 6.76 (d, 1 H,
J = 8.5 Hz, H-1), 6.70 (dd, 1 H, J = 1.9, 8.5
Hz, H-2), 4.45 (d, 1 H, J = 10.2 Hz, H-9), 4.32 (d, 1 H,
J = 10.2 Hz, H-9), 4.31 (t, 1 H, J = 8.8 Hz, H-11a),
3.88 (s, 3 H, OMe), 3.75 (s, 3 H, OMe), 3.39 (d, 1 H, J = 15.0
Hz, H-7), 3.21 (d, 1 H, J = 15.0 Hz, H-7), 2.93 (m, 1 H,
H-6), 2.89 (t, 1 H, J = 8.8 Hz, H-11), 2.86 (m, 1 H, H-6),
2.70 (m, 2 H, H-5), 2.60 (t, 1 H, J = 8.8 Hz, H-11). ¹³C
NMR (125 MHz, DMSO-d6): δ = 166.3 (q),158.8
(q), 143.4 (q), 140.0 (q), 139.0 (q), 138.3 (q), 132.9 (q), 131.8
(CH), 130.4 (CH), 128.9 (q), 128.7 (CH), 127.4 (q), 126.3 (CH),
114.2 (CH), 111.7 (CH), 70.9 (CH), 62.8 (CH2), 56.4 (CH2),
55.5 (CH3), 52.6 (CH3), 38.6 (CH2), 30.5
(CH2), 28.5 (CH2). IR (KBr): 2931, 1717, 1606,
1252, 1111 cm-¹.
Compound 15a: ¹H NMR (500 MHz,
CDCl3): δ = 8.14 (d, 1 H, J = 1.0
Hz, H-15), 7.96 (dd, 1 H, J = 8.0, 1.0 Hz, H-17), 7.36
(d, 1 H, J = 8.0 Hz, H-18), 7.20 (d, 1 H, J = 8.5
Hz, H-13), 7.11 (m, 2 H, H-11 and H-12), 7.04 (d, 1 H, J = 8.5
Hz, H-10), 6.87 (d, 1 H, J = 2.5 Hz, H-4), 6.81 (d, 1 H,
J = 8.5 Hz, H-1), 6.68 (dd, 1 H, J = 2.5, 8.5
Hz, H-2), 3.90 (s, 3 H, OMe), 3.88 (d, 1 H, J = 17.8 Hz,
H-9), 3.83 (d, 1 H, J = 17.8 Hz, H-9), 3.74 (s, 3 H, OMe),
3.52 (t, 1 H, J = 13.0 Hz, H-14), 3.19 (d, 1 H, J = 14.7
Hz, H-7), 3.15 (d, 1 H, J = 14.7 Hz, H-7), 3.15 (t, 1 H,
J = 13.0 Hz, H-14a), 2.96 (d, 1 H, J = 13.0 Hz,
H-14), 2.81 (m, 2 H, H-5), 2.66 (m, 1 H, H-6), 2.51 (m, 1 H, H-6). ¹³C
NMR (125 MHz, CDCl3): δ = 166.6 (q), 158.8
(q), 145.5 (q), 140.6 (q), 138.6 (q), 135.3 (q), 134.6 (q), 133.6
(q), 129.1 (CH), 128.8 (CH), 128.7 (q), 128.2 (CH), 127.0 (CH),
126.9 (q), 126.4 (2 × CH), 126.3 (CH), 126.1
(CH), 114.2 (CH), 111.6 (CH), 58.2 (CH), 57.1 (CH2), 56.7
(CH2), 55.6 (CH3), 52.7 (CH3),
32.7 (CH2), 32.6 (CH2), 28.8 (CH2).
IR (KBr): 2928, 1717, 1606, 1251, 1109 cm-¹.
Compound 21b: ¹H NMR (500 MHz,
CDCl3): δ = 7.42 (d, 1 H, J = 8.4
Hz, H-9), 7.35 (t, 2 H, J = 8.4 Hz, Ph-3′ and
5′H), 7.29 (t, 1 H, J = 8.4 Hz, Ph-4′H),
7.06 (d, 2 H, J = 8.4 Hz, Ph-2′ and 6′H),
6.87 (d, 1 H, J = 3.6 Hz, H-6), 6.83 (dd, 1 H, J = 8.4,
3.6 Hz, H-8), 6.43 (s, 1 H, H-3), 5.19 (d, 1 H, J = 16.8 Hz,
CH2Ph), 5.11 (d, 1 H, J = 16.8 Hz, CH2Ph),
4.31 (q, 1 H, J = 7.6 Hz, CHCH3), 3.85 (s, 3
H, OMe), 3.51 (s, 3 H, CO2Me), 2.86 (m, 2 H, H2-4),
2.68 (m, 2 H, H2-5), 1.50 (d, 3 H, J = 7.6
Hz, CHCH3). ¹³C NMR (125
MHz, CDCl3): δ = 174.2 (q), 157.0 (q),
138.9 (q), 138.6 (q), 128.6 (2 × CH), 127.3
(2 × CH), 126.4 (CH), 125.8 (q), 125.2
(q), 124.9 (CH), 120.5 (q), 118.6 (q), 117.2 (CH), 114.6 (CH), 111.5 (CH),
55.3 (CH3), 52.1 (CH3), 50.7 (CH2),
36.9 (CH), 32.0 (CH2), 21.2 (CH2), 16.1 (CH3).
IR (KBr): 2938, 1722, 1612, 1253, 1108 cm-¹.